• 1
    Stouffer RL (2006) Structure, function, and regulation of the corpus luteum. In The Physiology of Reproduction (Neill JD, ed.), pp. 475526. Elsevier/Academic Press, San Diego, CA.
  • 2
    Stocco C, Telleria C & Gibori G (2007) The molecular control of corpus luteum formation, function, and regression. Endocrin Rev 28, 117149.
  • 3
    Davis JS & Rueda BR (2002) The corups luteum: an ovarian structure with maternal instincts and suicidal tendencies. Front Biosci 7, d1949d1978.
  • 4
    Funk CD, Song W-C & FitzGerald GA (2009) Prostaglandins and other lipid mediators in reproductive medicine. In Reproductive Endocrinology (Strauss JF 3rd & Barbieri RL, eds), 6th edn., pp. 121137. Saunders, Philadelphia, PA.
  • 5
    Blaho VA & Hla T (2011) Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors. Chem Rev 111, 62996320.
  • 6
    Nakanaga K, Hama K & Aoki J (2010) Autotaxin – an LPA producing enzyme with diverse functions. J Biochem 148, 1324.
  • 7
    Aoki J, Inoue A & Okudaira S (2008) Two pathways for lysophosphatidic acid production. Biochim Biophys Acta 1781, 513518.
  • 8
    Ye X (2008) Lysophospholipid signaling in the function and pathology of the reproductive system. Human Reprod Update 14, 519536.
  • 9
    Ye X & Chun J (2009) Lysophosphatidic acid (LPA) signaling in vertebrate reproduction. Trends Endocrinol Metab 21, 1724.
  • 10
    Kurusu S, Motegi T, Kawaminami M & Hashimoto I (1998) Expression and cellular distribution of cytosolic phospholipase A2 in the rat ovary. Prostag Leukotr Ess 58, 399404.
  • 11
    Kurusu S, Sakaguchi S, Kawaminami M & Hashimoto I (2001) Sustained activity of luteal cytosolic phospholipase A2 during luteolysis in pseudopregnant rats: its possible implication in tissue involution. Endocrine 14, 337342.
  • 12
    Huang MC, Lee HY, Yeh CC, Kong Y, Zaloudek CJ & Goetzl EJ (2004) Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA2). Oncogene 23, 122129.
  • 13
    Lee Z, Cheng C-T, Zhang H, Subler MA, Wu J, Mukherjee A, Windle JJ, Chen C-K & Fang X (2008) Role of LPA4/p2y9/GPR23 in negative regulation of cell motility. Mol Biol Cell 19, 54355445.
  • 14
    Zhang Z, Lee Y-C, Kim S-J, Choi MS, Tsai P-C, Saha A, Wei H, Xu Y, Xiao Y-J, Zhang P et al. (2007) Production of lysophosphatidylcholine by cPLA2 in the brain of mice lacking PPT1 is a signal for phagocyte infiltration. Human Mol Genet 16, 837847.
  • 15
    Peter C, Waibel M, Radu CG, Yang LV, Witte ON, Schulze-Osthoff K, Wesselborg S & Lauber K (2008) Migration of apoptotic ‘Find-me’ signals is mediated via the phagocyte receptor G2A. J Biol Chem 283, 52965305.
  • 16
    Inoue M, Ma L, Aoki J & Ueda H (2008) Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain. J Neurochem 107, 15561565.
  • 17
    Ma L, Uchida H, Nagai J, Inoue M, Aoki J & Ueda H (2010) Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain. J Pharmacol Exp Ther 333, 540546.
  • 18
    Chettibi S, Lawrence AJ, Stevenson RD & Young JD (1994) Effects of lysophosphatidic acid on motility, polarization and metabolic burst of human neutrophils. FEMS Immunol Med Microbiol 8, 271281.
  • 19
    Itagaki K, Kannan KB & Hauser CJ (2004) Lysophosphatidic acid triggers calcium entry through a non-store-operated pathway in human neutrophils. J Leukocyte Biol 77, 181189.
  • 20
    Gustin C, Van Steenbrugge M & Raes M (2008) LPA modulates monocyte migration directly and via LPA-stimulated endothelial cells. Am J Physiol Cell Physiol 295, C905C914.
  • 21
    Komachi M, Tomura H, Malchinkhuu E, Tobo M, Mogi C, Yamada T, Kimura T, Kuwabara A, Ohta H, Im DS et al. (2009) LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites. Carcinogenesis 30, 457465.
  • 22
    Fukui R, Tanabe E, Kitayoshi M, Yoshikawa K, Fukushima N & Tsujiuchi T (2012) Negative regulation of cell motile and invasive activities by lysophosphatidic acid receptor-3 in colon cancer HCT116 cells. Tumour Biol 33, 18991905.
  • 23
    Hayashi M, Okabe K, Kato K, Okamura M, Fukui R, Fukushima N & Tsujiuchi T (2012) Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells. Biochem Biophys Res Commun 316, 9196.
  • 24
    Soehnlein O & Lindbom L (2010) Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 10, 427439.
  • 25
    Zhao J, He D, Berdyshev E, Zhong M, Salgia R, Morris AJ, Smyth SS, Natarajan V & Zhao Y (2011) Autotaxin induces lung epithelial cell migration through lysoPLD activity-dependent and -independent pathways. Biochem J 439, 4555.
  • 26
    Hama K, Aoki J, Fukaya M, Kishi Y, Sakai T, Suzuki R, Ohta H, Yamori T, Watanabe M, Chun J et al. (2004) Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J Biol Chem 279, 1763417639.
  • 27
    van Corven EJ, Groenink A, Jalink K, Eichholtz T & Moolenaar WH (1989) Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell 59, 4554.
  • 28
    Lloret S, Torrent M & Morreno JJ (1996) Proliferation-dependent changes in arachidonic acid mobilization from phospholipids of 3T6 fibroblasts. Pflugers Arch 432, 655662.
  • 29
    Mitchell RA, Metz CN, Peng T & Bucala R (1999) Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. J Biol Chem 274, 1810018106.
  • 30
    Watanabe N, Ikeda H, Nakamura K, Ohkawa R, Kume Y, Tomiya T, Tejima K, Nishikawa T, Arai M, Yanase M et al. (2007) Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity. Life Sci 81, 10091015.
  • 31
    Oikonomou N, Mouratis MA, Tzouvelekis A, Kaffe E, Valavanis C, Vilaras G, Karameris A, Prestwich GD, Bouros D & Aidinis V (2012) Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis. Am J Respir Cell Mol Biol 47, 566574.
  • 32
    Tager AM, LaCamera P, Shea BS, Campanella GS, Selman M, Zhao Z, Polosukhin V, Wain J, Karimi-Shah BA, Kim ND et al. (2008) The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med 14, 4554.
  • 33
    Budnik LT & Brunswig-Spickenheier B (2005) Differential effects of lysolipids on steroid synthesis in cells expressing endogenous LPA2 receptor. J Lipid Res 46, 930941.
  • 34
    Kowalczyk-Zieba I, Boruszewska D, Saulnier-Blache JS, Lopez Da Costa L, Jankowska K, Skarzynski DJ & Woclawek-Potocka I (2012) Lysophosphatidic acid action in the bovine corpus luteum – an in vitro study. J Reprod Dev 58, 661671.
  • 35
    Smyth SS, Cheng H-Y, Miriyala S, Panchatcharam M & Morris AJ (2008) Roles of lysophosphatidic acid in cardiovascular physiology and disease. Biochim Biophys Acta 1781, 563570.
  • 36
    Morris AJ, Panchatcharam M, Cheng H-Y, Federico L, Fulkerson Z, Selim S, Escalante-Acalde D & Smyth SS (2009) Regulation of vascular cell function by bioactive lysophosphollipids. J Thromb Haemost 7, 3843.
  • 37
    Tokumura A, Kanaya Y, Miyake M, Yamano S, Irahara M & Fukuzawa K (2002) Increased production of bioactive lysophosphatidic acid by serum lysophospholipase D in human pregnancy. Biol Reprod 67, 13861392.
  • 38
    Tokumura A, Kume T, Taira S, Yasuda K & Kanzaki H (2009) Altered activity of lysophospholipase D, which produces bioactive lysophosphatidic acid and choline, in serum from women with pathological pregnancy. Mol Human Reprod 15, 301310.
  • 39
    Masuda A, Fujii T, Iwasawa Y, Nakamura K, Ohkawa R, Igarashi K, Okudaira S, Ikeda H, Kozuma S, Aoki J et al. (2011) Serum autotaxin measurements in pregnant women: Application for the differentiation of normal pregnancy and pregnancy-induced hypertension. Clin Chim Acta 412, 19441950.
  • 40
    Tokumura A, Miyake M, Nishioka Y, Yamano S, Aono T & Fukuzawa K (1999) Production of lysophosphatidic acid by lysophospholipase D in human follicular fluids of in vitro fertilization patients. Biol Reprod 61, 195199.
  • 41
    Yao B & Kawaminami M (2008) Stimulation of annexin A5 expression by gonadotropin releasing hormone (GnRH) in the Leydig cells of rats. J Reprod Dev 54, 259264.
  • 42
    Abe T, Toida D, Satoh H, Yonezawa T, Kawaminami M & Kurusu S (2011) An early single dose of progesterone agonist attenuates endogenous progesterone surge and reduces ovulation rate in immature rat model of induced ovulation. Steroids 76, 11161125.
  • 43
    Kurusu S, Sapirstein A & Bonventre JV (2012) Group IVA phospholipase A2 optimizes ovulation and fertilization in rodents through induction of and metabolic coupling with prostaglandin endoperoxide synthase 2. FASEB J 26, 38003810.
  • 44
    Greenwald G & Rothchild I (1968) Formation and maintenance of corpora lutea of experimental animals. J Anim Sci 27, 139162.
  • 45
    Nio-Kobayashi J & Iwanaga T (2010) Differential cellular localization of galectin-1 and galectin-3 in the regressing corpus luteum of mice and their possible contribution of luteal cell elimination. J Histochem Cytochem 58, 741749.
  • 46
    Tanaka M, Kishi Y, Takanezawa Y, Kakehi Y, Aoki J & Arai H (2004) Prostatic acid degrades lysophosphatidic acid in seminal plasma. FEBS Lett 571, 197204.